- Label RSS
Drug Label Info
Safety
- Report Adverse Events
- FDA Safety Recalls
- Presence in Breast Milk
Related Resources
- Medline Plus
- Clinical Trials
- PubMed
- All Citations
- Adverse Effects
- Therapeutic Use
- Pharmacology
- Clinical Trials
- Biochemical Data Summary
More Info For This Drug
- View Labeling Archives
- RxNorm
- Get Label RSS Feed
- View NDC Code(s)NEW!
- NDC Code(s): 84010-075-01
- Packager: Jiangxi Hemei Pharmaceutical Co., Ltd
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated February 20, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
View All Sections
- Active Ingredient
Tolnaftate 1%
- Purpose
Antifungal
- Use
.Effectivein treating athlete's foot (tineapedis）
.Helps prevent athlete's foot with regular use
.For effective relief ofitching, cracking, burning, scaling and discomfort
- Warnings
For external use only
Extremely Flammable do not use while smoking or near heat or flame. - Do not use
on children under 2 years of age unless directed by a doctor.
- When Using
this product avoid contact with the eyes
.Use only as directed. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal.
.Do not puncture or incinerate. Contents under pressure, Do not store at temperatures above 120°F - Stop Use
·Irritation occurs
·There is no improvement within 4 weeks. - Ask Doctor
·Irritation occurs
·There is no improvement within 4 weeks. - Keep Out Of Reach Of Children
If swallowed, get medical help or contact a poison control center right away.
- Directions
·Wash the affected area and dry thoroughly
·Shake can well and spray a thin layer over affected area twice daily (morning and night)
·Supervise children in the use of this product
·pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once
daily
·Use daily for 4 weeks; if condition persists longer, ask a doctor
·To prevent athlete's foot, apply once or twice daily (morning and/or night, or as directed by a doctor)
·This product is not effective on the scalp or nails. - Other information
Store between 20-25°C (68-77°F)
- Inactive ingredients
alcohol，benzoic acid，euphorbia hirta whole，phellodendron amurense bark，phenylephrine hydrochloride，pseudolarix
amabilis bark，salicylic acid，sophora flavescens root，Probiotic. - PRINCIPAL DISPLAY PANEL
- INGREDIENTS AND APPEARANCE
ALVEORA FOOT ODOR PROBIOTIC
tolnaftate 1% foot odor probiotic sprayProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:84010-075 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE 1g in100mL Inactive Ingredients Ingredient Name Strength PHELLODENDRON AMURENSE BARK (UNII: PBG27B754G) SALICYLIC ACID (UNII: O414PZ4LPZ) ALCOHOL (UNII: 3K9958V90M) PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) BENZOIC ACID (UNII: 8SKN0B0MIM) SOPHORA FLAVESCENS ROOT (UNII: IYR6K8KQ5K) EUPHORBIA HIRTA WHOLE (UNII: L13YF113GN) PSEUDOLARIX AMABILIS BARK (UNII: 49G13A93VE) LACTOBACILLUS ACIDOPHILUS (UNII: 1PRR1V42V5) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:84010-075-01 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 02/21/2025 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M005 02/21/2025 Labeler -Jiangxi Hemei Pharmaceutical Co., Ltd(724892056)
Establishment Name Address ID/FEI Business Operations Jiangxi Hemei Pharmaceutical Co., Ltd 724892056 manufacture(84010-075)
View All Sections
Find additional resources
(also available in the left menu)
Safety
Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk
Related Resources
Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary
More Info on this Drug
View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!
View Labeling Archives for this drug
ALVEORA FOOT ODOR PROBIOTIC- tolnaftate 1% foot odor probiotic spray
Number of versions: 1
| Published Date (What is this?) | Version | Files |
|---|---|---|
| Feb 24, 2025 | 1 (current) | download |
RxNorm
ALVEORA FOOT ODOR PROBIOTIC- tolnaftate 1% foot odor probiotic spray
Under Review - Editing is pending for RxNorm. If in scope, these drugs will include RxNorm normal forms when editing is complete.
Get Label RSS Feed for this Drug
ALVEORA FOOT ODOR PROBIOTIC- tolnaftate 1% foot odor probiotic spray
To receive this label RSS feed
Copy the URL below and paste it into your RSS Reader application.
https://dailymed.nlm.nih.gov/dailymed/labelrss.cfm?setid=2e9e250a-2260-b144-e063-6394a90a4f54
To receive all DailyMed Updates for the last seven days
Copy the URL below and paste it into your RSS Reader application.
https://dailymed.nlm.nih.gov/dailymed/rss.cfm
What will I get with the DailyMed RSS feed?
DailyMed will deliver notification of updates and additions to Drug Label information currently shown on this site through its RSS feed.
DailyMed will deliver this notification to your desktop, Web browser, or e-mail depending on the RSS Reader you select to use. To view updated drug label links, paste the RSS feed address (URL) shown below into a RSS reader, or use a browser which supports RSS feeds, such as Safari for Mac OS X.
How to discontinue the RSS feed
If you no longer wish to have this DailyMed RSS service, simply delete the copied URL from your RSS Reader.
Why is DailyMed no longer displaying pill images on the Search Results and Drug Info pages?
Due to inconsistencies between the drug labels on DailyMed and the pill images provided by RxImage, we no longer display the RxImage pill images associated with drug labels.
We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in the drug labels.
NDC Codes
ALVEORA FOOT ODOR PROBIOTIC- tolnaftate 1% foot odor probiotic spray
If this SPL contains inactivated NDCs listed by the FDA initiated compliance action, they will be specified as such.
| NDC | |
|---|---|
| 1 | 84010-075-01 |
